AOD Effects and Consequences Clinical Trial
Official title:
Using Memantine in Treating Bipolar Disorder Comorbid With Alcoholism
Since memantine may not only inhibit overactivity of microglial cell, but also repair the damaged neurons and neurogenesis through activation of astroglial cell and release of neurotrophic factors, the investigators propose that the neurotrophic effect of memantine may benefit neurodegenerative diseases including bipolar disorders (BP) and alcohol dependence. In the current study, the investigator will investigate whether add-on memantine at a dose of 5 mg/day has a beneficial effect on BP comorbid with alcohol dependence.
Each individual enter into this project will receive regulate treatment adding-on memantine medication. During each visit, patients will receive evaluation for their symptoms and plasma Brain-Derived Neurotropic Factor (BDNF), cytokines (e.g.., Interleukin-6(IL-6), IL-8) and neuropsychological performance. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02515526 -
Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein
|
N/A | |
| Completed |
NCT01577706 -
Spectroscopic Imaging at 4T: A Drug Challenge Study
|
N/A |